Shuttle Pharmaceuticals Holdings (SHPH) Share-based Compensation (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Share-based Compensation of $33334.0 for Q1 2026, up 416575.0% year-over-year from N/an in Q1 2025, and down 84.48% quarter-over-quarter from $214750.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Share-based Compensation (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Share-based Compensation history runs 6 years deep, the most recent figure standing at $33334.0 for Q1 2026.
- In Q1 2026, Share-based Compensation rose 416575.0% year-over-year to $33334.0; the TTM figure through Mar 2026 stood at $429255.0 (up 189.44% YoY), while the FY2025 annual figure was $932967.0, up 3.66% from the prior year.
- Share-based Compensation for Q1 2026 stood at $33334.0, down from $214750.0 in the prior quarter.
- The five-year high for Share-based Compensation was $300000.0 in Q2 2023, with the low at -$119186.0 in Q4 2022.
- The 5-year median for Share-based Compensation is $46853.0 (2025), against an average of $79038.8.
- The sharpest annual moves came in 2022 and 2026: Share-based Compensation tumbled 121.97% in 2022, then soared 416575.0% in 2026.
- Shuttle Pharmaceuticals Holdings' Share-based Compensation stood at -$119186.0 in 2022, then soared by 172.59% to $86522.0 in 2023, then slumped by 63.18% to $31858.0 in 2024, then surged by 574.09% to $214750.0 in 2025, then slumped by 84.48% to $33334.0 in 2026.
- Business Quant data shows SHPH's Share-based Compensation at $33334.0 in Q1 2026, $214750.0 in Q4 2025, and $134318.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - | 35,018.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33,334.00 |
| Mar 31, 2026 | 33,334.00 |
| Dec 31, 2025 | 214,750.00 |
| Dec 31, 2025 | 214,750.00 |
| Sep 30, 2025 | 134,318.00 |
| Sep 30, 2025 | 134,318.00 |
| Jun 30, 2025 | 46,853.00 |
| Jun 30, 2025 | 46,853.00 |
| Mar 31, 2025 | 8.00 |
| Mar 31, 2025 | 8.00 |
| Dec 31, 2024 | 31,858.00 |
| Dec 31, 2024 | 31,858.00 |
| Sep 30, 2024 | 45,275.00 |
| Sep 30, 2024 | 45,275.00 |
| Jun 30, 2024 | 71,162.00 |
| Jun 30, 2024 | 71,162.00 |
| Mar 31, 2024 | 111,449.00 |
| Mar 31, 2024 | 111,449.00 |
| Dec 31, 2023 | 86,522.00 |
| Dec 31, 2023 | 86,522.00 |